Rosie, a Health Education Question-and-Answer Chatbot for New Mothers: Randomized Pilot Study.
Rosie, a Health Education Question-and-Answer Chatbot for New Mothers: Randomized Pilot Study.
复制标题
DOI：
10.2196/51361
复制
发表时间：
2024-01-12
影响因子：
2.2
通讯作者：
Boyd-Graber, Jordan
中科院分区：
文献类型：
--
作者：
Nguyen, Quynh C;Aparicio, Elizabeth M;Jasczynski, Michelle;Channell Doig, Amara;Yue, Xiaohe;Mane, Heran;Srikanth, Neha;Gutierrez, Francia Ximena Marin;Delcid, Nataly;He, Xin;Boyd-Graber, Jordan
孕产妇和儿童的结果存在明显差异，需要提供及时和准确的保健信息。在这项试点研究中，我们评估了有色人种新妈妈的健康聊天机器人的可行性和可接受性。罗茜是一款问答聊天机器人，是一款移动应用程序，可以回答有关怀孕、育儿和儿童发展的问题。从2023年1月9日到2023年2月9日，参与者通过社交媒体帖子和社区组织参与招募。纳入标准包括年龄≥14岁、有色人种女性、目前怀孕或在过去6个月内分娩。参与者被随机分配到Rosie治疗组（15/ 29,52%的人使用Rosie应用程序）或对照组（14/ 29,48%的人每月使用一本儿童书籍），为期3个月。那些被分配到治疗组的人可以向罗西提问，并从罗西的知识库中立即得到回应。一旦发现可能的健康紧急情况，Rosie会发送紧急资源和相关热线信息。此外，一名临床社会工作者在24小时内与参与者进行随访。完成了干预前和干预后测试，以定性和定量地评估Rosie，并描述了主要健康结果的变化，包括产后抑郁症和急诊室就诊频率。这些测量结果用于临床试验的样本量计算。在41名被筛选并符合条件的个体中，31名（76%）被纳入研究，29名（71%）被保留在研究中。在为期3个月的研究期间，超过87%（13/15）的Rosie治疗组成员报告每天（5/15,33%）或每周（8/15,53%）使用Rosie。大多数用户报告说，Rosie很容易使用（14/ 15,93%），并提供快速的响应（13/ 15,87%）。剩下的问题包括应用程序崩溃（8/15,53%），用户对Rosie的一些回答不满意（12/15,80%）。罗西治疗组和对照组的母亲在测试前和测试后的抑郁评分都有所下降，但只有治疗组母亲的抑郁评分下降有统计学意义（P= 0.008）。此外，与对照组（3/ 13.23%）相比，治疗组婴儿急诊室就诊比例较低（1/ 11.9%）。但组间差异无统计学意义（P< 0.05）。由于聊天机器人能够提供个性化、灵活的工具，在母亲和孩子健康风险升高的时期，为个人提供高质量健康信息的及时性和可及性，因此，对于少数民族和种族的孕妇和婴儿母亲来说，Rosie是一种可接受、可行和适当的干预措施。ClinicalTrials.gov NCT06053515;https://clinicaltrials.gov/study/NCT06053515
Stark disparities exist in maternal and child outcomes and there is a need to provide timely and accurate health information. In this pilot study, we assessed the feasibility and acceptability of a health chatbot for new mothers of color. Rosie, a question-and-answer chatbot, was developed as a mobile app and is available to answer questions about pregnancy, parenting, and child development. From January 9, 2023, to February 9, 2023, participants were recruited using social media posts and through engagement with community organizations. Inclusion criteria included being aged ≥14 years, being a woman of color, and either being currently pregnant or having given birth within the past 6 months. Participants were randomly assigned to the Rosie treatment group (15/29, 52% received the Rosie app) or control group (14/29, 48% received a children’s book each month) for 3 months. Those assigned to the treatment group could ask Rosie questions and receive an immediate response generated from Rosie’s knowledgebase. Upon detection of a possible health emergency, Rosie sends emergency resources and relevant hotline information. In addition, a study staff member, who is a clinical social worker, reaches out to the participant within 24 hours to follow up. Preintervention and postintervention tests were completed to qualitatively and quantitatively evaluate Rosie and describe changes across key health outcomes, including postpartum depression and the frequency of emergency room visits. These measurements were used to inform the clinical trial’s sample size calculations. Of 41 individuals who were screened and eligible, 31 (76%) enrolled and 29 (71%) were retained in the study. More than 87% (13/15) of Rosie treatment group members reported using Rosie daily (5/15, 33%) or weekly (8/15, 53%) across the 3-month study period. Most users reported that Rosie was easy to use (14/15, 93%) and provided responses quickly (13/15, 87%). The remaining issues identified included crashing of the app (8/15, 53%), and users were not satisfied with some of Rosie’s answers (12/15, 80%). Mothers in both the Rosie treatment group and control group experienced a decline in depression scores from pretest to posttest periods, but the decline was statistically significant only among treatment group mothers (P=.008). In addition, a low proportion of treatment group infants had emergency room visits (1/11, 9%) compared with control group members (3/13, 23%). Nonetheless, no between-group differences reached statistical significance at P<.05. Rosie was found to be an acceptable, feasible, and appropriate intervention for ethnic and racial minority pregnant women and mothers of infants owing to the chatbot’s ability to provide a personalized, flexible tool to increase the timeliness and accessibility of high-quality health information to individuals during a period of elevated health risks for the mother and child. ClinicalTrials.gov NCT06053515; https://clinicaltrials.gov/study/NCT06053515